Clinical Trials and Studies According to a clinical trial for weight reduction and long-term maintenance studies in adults with obesity or overweight, after 68 weeks, Wegovy treatment led to a significant decrease in body weight compared to the placebo group
As For example, recent studies have found that GLP-1 medications may be linked to improved Previous research has also associated GLP-1 drugs to a decreased risk for certain cancers, including endometrial cancer, GLP1 receptor agonists are biologically Medical News Today
Last reviewed: June 28, 2026 Last updated: June 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
In one of the largest clinical trials, people taking tirzepatide alongside lifestyle support lost an average of around 15-21% of their body weight over approximately 72 weeks, depending on the dose used
People who have struggled for years often describe the experience as: Finally being able to eat normally without feeling deprived Feeling full on smaller portions Seeing results without extreme dieting Feeling in control of food choices again Instead of fighting biology, they partner with it
